These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1133 related articles for article (PubMed ID: 10288422)
21. Preferred provider organizations: an antitrust warning. Sandler AL Group Pract J; 1987; 36(6):41-2, 44. PubMed ID: 10284861 [No Abstract] [Full Text] [Related]
22. Law-medicine notes: Health planning, Blue Cross, and the federal antitrust laws. Curran WJ N Engl J Med; 1981 Nov; 305(20):1194-5. PubMed ID: 6169992 [No Abstract] [Full Text] [Related]
23. Antitrust issues in health care planning. Decker R Hosp Purch Manage; 1982 Feb; 7(2):14-6. PubMed ID: 10254100 [No Abstract] [Full Text] [Related]
29. Competitive bidding: they're singing the blues in Cleveland. Onusko TJ Healthc Financ Manage; 1986 Feb; 40(2):64-8. PubMed ID: 10275007 [TBL] [Abstract][Full Text] [Related]
30. Antitrust and the new competition in health care: excerpts. Ginsburg DH Med Prod Sales; 1986 Apr; 17(4):39-42. PubMed ID: 10276459 [No Abstract] [Full Text] [Related]
31. Antitrust implications of "all-inclusive" payment methodologies: the Empire Blue Cross decision. Miles JJ Health Law Vigil; 1987 Jun; 10(13):5-7. PubMed ID: 10282184 [No Abstract] [Full Text] [Related]
32. More private, less government PPA antitrust action. Burda D Hospitals; 1987 Feb; 61(3):52. PubMed ID: 3804258 [No Abstract] [Full Text] [Related]
33. Court: Indiana Blues may adopt PPO plan without antitrust scrutiny. Allen HS; Rothschild IS Health Law Vigil; 1986 Apr; 9(8):4-5. PubMed ID: 10278389 [No Abstract] [Full Text] [Related]
35. Alternative delivery systems are focus of antitrust scrutiny. Scammon DL; Fuller DA; Sheffet MJ J Health Care Mark; 1987 Jun; 7(2):77-81. PubMed ID: 10282715 [No Abstract] [Full Text] [Related]
36. Challenge to Blues' tax-exemption seen as signal to healthcare industry. Anderson HJ; Baldwin MF Mod Healthc; 1985 Dec; 15(25):18-20. PubMed ID: 10274654 [No Abstract] [Full Text] [Related]
38. Examining exclusionary conduct of HMOs and PPOs: a case comment on Northwest Medical Laboratories v. Blue Cross and Blue Shield of Oregon. Levitt DM Am J Law Med; 1991; 17(3):271-88. PubMed ID: 1785621 [TBL] [Abstract][Full Text] [Related]
39. The development of preferred provider organizations and its antitrust implications. Maram BS J Med Pract Manage; 1985 Oct; 1(2):130-5. PubMed ID: 10281825 [TBL] [Abstract][Full Text] [Related]
40. Comment on Kartell v. Blue Shield of Massachusetts, Inc.: an antitrust analysis of Blue Shield's reimbursement schemes. Wayne AB Am J Law Med; 1986; 11(4):465-500. PubMed ID: 3591810 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]